Donor Epidemiology

Donor Epidemiology

Our ambition is to monitor and evaluate the variability within our donor base.

Donor Infectious Disease Epidemiology

  • Contribute to public health policy by tracking the incidence, prevalence and/or progression infectious dieases in a healthy donor population

Key Findings


              HLA Associations with Disease Presentation and Progression

              • To compare the distribution of Human Leukocyte Antigen (HLA) genotypes in patients with healthy Irish Donors

              Key findings 

              Donor Blood Antigen Profiling

              • Ireland's population is increasing and becoming more diverse, this has potential implications for the Irish Blood Transfusion Service to provide ‘best-matched’ blood for the optimal care of patients
              • Determine the distribution of ABO, RH and other clinically significant blood group antigen systems in Irish donorsand compare with those required for transfusion in various patient groups


              On-going Research

              • Continued monitoring the SARS-CoV-2 serological profile in blood donors to support public health surveillance and vaccinations programmes.
              • Estimation of Cytomegalovirus seroprevalence and seroconversion rates in an Irish donors.
              • Molecular epidemiology of Hepatitis E virus in Irish blood donors.
              • Association of HLA type with ANCA Vasculitis
              • Link between paediatric chronic illness and HLA types
              • Enhanced donor antigen matching for patients at risk of alloimmunisation 
                Sign up to Our Newsletter

                Sign up to Our Newsletter

                loading form...